Comparison · NCT01235546-a01dae7a
Placebo With Standard Prophylaxis vs Azithromycin (Zithromax) With Standard Prophylaxis: Maternal Fever
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Placebo With Standard Prophylaxis vs Azithromycin (Zithromax) With Standard Prophylaxis: Maternal Fever. Trial comparisons, record NCT01235546-a01dae7a. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01235546-a01dae7a
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0817 | 0.0662 | 0.1 | wilson | |
| Risk in group 2 | 0.0501 | 0.0383 | 0.0653 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0316 | 0.00989 | 0.0537 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.63 | 1.16 | 2.29 | log | |
| Odds ratio, group 1 over group 2 | 1.69 | 1.17 | 2.42 | log | |
| Number needed to treat, for one more participant with the outcome on Placebo With Standard Prophylaxis than on Azithromycin (Zithromax) With Standard Prophylaxis | 31.7 | 18.6 | 101 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Placebo With Standard Prophylaxis | Placebo: 250 cc normal saline Standard Prophylaxis: standard cephalosporin prophylaxis | 81 | 992 | OG000 |
| Group 2 | Azithromycin (Zithromax) With Standard Prophylaxis | Azithromycin: 500 mg in 250 cc normal saline 1 time dose Standard Prophylaxis: standard cephalosporin prophylaxis | 51 | 1,018 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- OTHER_PRE_SPECIFIED
- Title
- Maternal Fever
- Description
- Time frame
- Up to 6 weeks after delivery
- Population
- Postpartum Fever
Source ClinicalTrials.gov
Trial
- Title
- Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean Infection
- NCT number
- NCT01235546
- Phases
- NA
- Conditions
- Endometritis, Wound Infection, Abscess, Surgical Site Infection
- Interventions
- Azithromycin and standard of care, Placebo and standard of care
- Lead sponsor
- Alan Tita
- Results first posted
- 2017-07-28
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01235546?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01235546-a01dae7a